TRINITY BIOTECH PLC(TRIB)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,598 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
TRIB Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for TRINITY BIOTECH PLC (TRIB), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TRIB at 26.9/100 on a 32-signal composite quality model, placing it at rank #2,598 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2024), TRINITY BIOTECH PLC reports quarterly revenue of $61.6M, net income of $-31.2M. Top institutional holders of TRIB by reported 13-F value include HUNTER ASSOCIATES INVESTMENT MANAGEMENT, Williams & Novak, SUSQUEHANNA INTERNATIONAL GROUP, LLP, based on the most recent SEC filings. TRIB trades on the Nasdaq exchange and files with the SEC under CIK 888721. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TRIB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TRINITY BIOTECH PLC directly from SEC EDGAR. TRINITY BIOTECH PLC's 13F Pro composite quality score has ranged between 26 and 29 since 2026, currently 26.9 — a stable long-term trajectory across 47 quarterly and live scoring snapshots.
Revenue
FY 2024
$61.6M
Net Income
FY 2024
$-31.2M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+8.3% YoYTotal Assets
+73.8% YoY| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $61.6M +8.3% | $56.8M -9.1% | $62.5M -23.0% | $81.1M -20.4% | $102.0M +12.8% | $90.4M |
| Total Assets | $103.3M +73.8% | $59.4M -35.5% | $92.1M -22.5% | $118.9M -8.8% | $130.4M -0.5% | $131.1M |
Get alerted when TRIB's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for TRINITY BIOTECH PLC including:
Top Institutional Holders of TRIB
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC
$251.0K661,210 shWilliams & Novak, LLC
$54.6K140,543 shSUSQUEHANNA INTERNATIONAL GROUP, LLP
$19.4K49,700 shSUSQUEHANNA INTERNATIONAL GROUP, LLP
$10.4K26,859 shMoss Adams Wealth Advisors LLC
$10.0K25,666 shCambridge Investment Research Advisors, Inc.
$9.0K22,280 shINSPIRION WEALTH ADVISORS, LLC
$8.9K25,000 shRAYMOND JAMES FINANCIAL INC
$7.9K20,319 shBECKER CAPITAL MANAGEMENT INC
$7.0K18,000 shLPL Financial LLC
$6.9K17,668 sh
| Fund | Value | Shares |
|---|---|---|
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | $251.0K | 661,210 |
| Williams & Novak, LLC | $54.6K | 140,543 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $19.4K | 49,700 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $10.4K | 26,859 |
| Moss Adams Wealth Advisors LLC | $10.0K | 25,666 |
| Cambridge Investment Research Advisors, Inc. | $9.0K | 22,280 |
| INSPIRION WEALTH ADVISORS, LLC | $8.9K | 25,000 |
| RAYMOND JAMES FINANCIAL INC | $7.9K | 20,319 |
| BECKER CAPITAL MANAGEMENT INC | $7.0K | 18,000 |
| LPL Financial LLC | $6.9K | 17,668 |
Companies Similar to TRIB
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Cellectis S.A.
IMMUTEP Ltd
MANNATECH INC
Valneva SE
Nanobiotix S.A.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put TRIB on your watchlist
Track score changes the day TRINITY BIOTECH PLC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is TRIB a good stock to buy?
13F Pro's AI-powered analysis of TRINITY BIOTECH PLC (TRIB) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for TRIB are available on the TRIB stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. TRIB is classified as a mid company.
Which hedge funds own TRIB?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling TRIB. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of TRINITY BIOTECH PLC's investment landscape.